Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-up

BACKGROUND AND OBJECTIVE: Erythropoietin (EPO) is a candidate neuroprotective drug. We assessed its long-term safety and efficacy as an adjunct to methylprednisolone in patients with optic neuritis and focused on conversions to multiple sclerosis (MS). METHODS: The TONE trial randomized 108 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Küchlin, Sebastian, Ihorst, Gabriele, Grotejohann, Birgit, Beisse, Flemming, Heinrich, Sven P., Albrecht, Philipp, Ungewiss, Judith, Wörner, Michael, Hug, Martin J., Wolf, Sebastian, Diem, Ricarda, Lagrèze, Wolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136679/
https://www.ncbi.nlm.nih.gov/pubmed/37094997
http://dx.doi.org/10.1212/NXI.0000000000200067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136679/
https://www.ncbi.nlm.nih.gov/pubmed/37094997
http://dx.doi.org/10.1212/NXI.0000000000200067

Ejemplares similares